Abstract
Purpose As breast cancer survivors (BCS) increasingly use complementary and alternative medicine, randomized controlled trials (RCT) are needed to assess the safety and efficacy of these therapies to guide appropriate clinical use. However, many RCTs face poor patient accrual, especially among populations at risk for health disparities. The purpose of this study is to quantify the barriers to participation in an acupuncture clinical trial among BCS, and to identify the socio-demographic factors associated with these barriers.
Highlights
As breast cancer survivors (BCS) increasingly use complementary and alternative medicine, randomized controlled trials (RCT) are needed to assess the safety and efficacy of these therapies to guide appropriate clinical use
The purpose of this study is to quantify the barriers to participation in an acupuncture clinical trial among BCS, and to identify the socio-demographic factors associated with these barriers
Of the 300 participants, 148 (49.8%) were willing to participate in an acupuncture clinical trial
Summary
As breast cancer survivors (BCS) increasingly use complementary and alternative medicine, randomized controlled trials (RCT) are needed to assess the safety and efficacy of these therapies to guide appropriate clinical use. Many RCTs face poor patient accrual, especially among populations at risk for health disparities. The purpose of this study is to quantify the barriers to participation in an acupuncture clinical trial among BCS, and to identify the socio-demographic factors associated with these barriers
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have